| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.71B | 54.73B | 49.75B | 45.22B | 39.97B | 36.02B |
| Gross Profit | 13.64B | 13.45B | 12.27B | 11.37B | 9.50B | 8.08B |
| EBITDA | 4.36B | 4.43B | 3.96B | 3.71B | 2.93B | 2.11B |
| Net Income | 2.77B | 2.84B | 2.78B | 2.76B | 2.05B | 1.36B |
Balance Sheet | ||||||
| Total Assets | 41.85B | 43.81B | 41.12B | 37.44B | 34.19B | 30.18B |
| Cash, Cash Equivalents and Short-Term Investments | 7.84B | 8.18B | 7.90B | 8.80B | 9.20B | 7.74B |
| Total Debt | 1.91B | 1.79B | 1.88B | 1.84B | 1.97B | 2.01B |
| Total Liabilities | 15.82B | 17.76B | 17.04B | 15.76B | 14.69B | 12.31B |
| Stockholders Equity | 25.47B | 25.50B | 23.58B | 21.28B | 19.14B | 17.54B |
Cash Flow | ||||||
| Free Cash Flow | 664.18M | 1.49B | 528.39M | 1.18B | 2.03B | 1.94B |
| Operating Cash Flow | 879.09M | 3.13B | 1.50B | 2.13B | 2.31B | 2.15B |
| Investing Cash Flow | -363.99M | -2.31B | -1.25B | -1.57B | -764.52M | -466.25M |
| Financing Cash Flow | -291.58M | -1.07B | -1.24B | -1.08B | -496.86M | -649.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥28.60B | 7.79 | ― | 4.06% | 5.36% | 12.84% | |
74 Outperform | ¥23.11B | 46.66 | ― | 2.77% | -4.47% | -24.47% | |
69 Neutral | ¥72.33B | 10.78 | 7.00% | 3.02% | 15.78% | ― | |
65 Neutral | ¥20.98B | 10.67 | ― | ― | -2.84% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥28.03B | -53.89 | ― | 3.56% | -3.85% | -45.64% | |
59 Neutral | ¥31.44B | 4.17 | ― | 2.13% | 1.13% | -66.14% |